Fig. 3.
Fig. 3. Development of hyperbilirubinemia in BMT recipients. Bilirubin levels (mean ± SD) were significantly elevated (*P < .05) in patients with (▪) VOD (n = 7) as compared with patients with (▴) GVHD (n = 7) or (▾) other liver damage (n = 17)

Development of hyperbilirubinemia in BMT recipients. Bilirubin levels (mean ± SD) were significantly elevated (*P < .05) in patients with (▪) VOD (n = 7) as compared with patients with (▴) GVHD (n = 7) or (▾) other liver damage (n = 17)

Close Modal

or Create an Account

Close Modal
Close Modal